Virus 40 Factor and Leader Binding Protein-1/Late Simian of the Transcription Factors Ying-Yang-1 Down-Modulates the Binding and Expression to Individuals Infected by HIV In Vivo Administration of Recombinant IL-2

[1]  A. Lazzarin,et al.  Constitutive activation of STATs upon in vivo human immunodeficiency virus infection. , 1999, Blood.

[2]  E. Seto,et al.  Unlocking the mechanisms of transcription factor YY1: are chromatin modifying enzymes the key? , 1999, Gene.

[3]  R. Dewar,et al.  A randomized trial of high- versus low-dose subcutaneous interleukin-2 outpatient therapy for early human immunodeficiency virus type 1 infection. , 1999, The Journal of infectious diseases.

[4]  C. Bovolenta,et al.  A Selective Defect of IFN-γ- But Not of IFN-α-Induced JAK/STAT Pathway in a Subset of U937 Clones Prevents the Antiretroviral Effect of IFN-γ Against HIV-1 , 1999, The Journal of Immunology.

[5]  M. Malim,et al.  HIV-1 regulatory/accessory genes: keys to unraveling viral and host cell biology. , 1998, Science.

[6]  K. Roebuck,et al.  Human immunodeficiency virus type-1 transcription: role of the 5'-untranslated leader region (review). , 1998, International journal of molecular medicine.

[7]  Techung Lee,et al.  Proteolytic Regulation of the Zinc Finger Transcription Factor YY1, a Repressor of Muscle-restricted Gene Expression* , 1998, The Journal of Biological Chemistry.

[8]  F. Romerio,et al.  Repression of Human Immunodeficiency Virus Type 1 through the Novel Cooperation of Human Factors YY1 and LSF , 1998, Journal of Virology.

[9]  M. Giacca,et al.  Effects of subcutaneous interleukin-2 therapy on CD4 subsets and in vitro cytokine production in HIV+ subjects. , 1997, The Journal of clinical investigation.

[10]  J. Decaprio,et al.  Mitogenic stimulation of resting T cells causes rapid phosphorylation of the transcription factor LSF and increased DNA-binding activity. , 1997, Genes & development.

[11]  R. Siliciano,et al.  Quantification of latent tissue reservoirs and total body viral load in HIV-1 infection , 1997, Nature.

[12]  M. Clementi,et al.  Dynamics and modulation of human immunodeficiency virus type 1 transcripts in vitro and in vivo , 1996, Journal of virology.

[13]  J. Metcalf,et al.  Controlled trial of interleukin-2 infusions in patients infected with the human immunodeficiency virus. , 1996, The New England journal of medicine.

[14]  K. Smith,et al.  Rational interleukin 2 therapy for HIV positive individuals: daily low doses enhance immune function without toxicity. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[15]  M A Wainberg,et al.  cells by NF-kappa B / Rel transcription factors . myeloidtype 1 and cytokine gene expression in Regulation of human immunodeficiency virus , 1995 .

[16]  J. Metcalf,et al.  Increases in CD4 T lymphocytes with intermittent courses of interleukin-2 in patients with human immunodeficiency virus infection. A preliminary study. , 1995, The New England journal of medicine.

[17]  E. Hogan,et al.  Calpain Expression in Lymphoid Cells , 1995, The Journal of Biological Chemistry.

[18]  E. Vicenzi,et al.  Regulation of HIV expression by viral genes and cytokines , 1994, Journal of leukocyte biology.

[19]  M. Clerici,et al.  Inhibition of activation-induced programmed cell death and restoration of defective immune responses of HIV+ donors by cysteine protease inhibitors. , 1994, Journal of immunology.

[20]  R. Roeder,et al.  Characterization of a family of related cellular transcription factors which can modulate human immunodeficiency virus type 1 transcription in vitro , 1994, Molecular and cellular biology.

[21]  D. Margolis,et al.  Human transcription factor YY1 represses human immunodeficiency virus type 1 transcription and virion production , 1994, Journal of virology.

[22]  T. Taniguchi,et al.  The IL-2 IL-2 receptor system: A current overview , 1993, Cell.

[23]  B. Cullen,et al.  A comparison of regulatory features in primate lentiviruses. , 1992, AIDS research and human retroviruses.

[24]  B Z Levi,et al.  Cloning of a negative transcription factor that binds to the upstream conserved region of Moloney murine leukemia virus , 1992, Molecular and cellular biology.

[25]  R. Perry,et al.  Delta, a transcription factor that binds to downstream elements in several polymerase II promoters, is a functionally versatile zinc finger protein. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[26]  M. Atchison,et al.  Isolation of a candidate repressor/activator, NF-E1 (YY-1, delta), that binds to the immunoglobulin kappa 3' enhancer and the immunoglobulin heavy-chain mu E1 site. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[27]  Yang Shi,et al.  Transcriptional repression by YY1, a human GLI-Krüippel-related protein, and relief of repression by adenovirus E1A protein , 1991, Cell.

[28]  W. Haseltine,et al.  Molecular biology of the human immunodeficiency virus type 1 , 1991, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[29]  M. Horikoshi,et al.  Repression of HIV-1 transcription by a cellular protein. , 1991, Science.

[30]  U. Hansen,et al.  Transcription factor LSF binds two variant bipartite sites within the SV40 late promoter. , 1990, Genes & development.

[31]  M. Malim,et al.  Functional characterization of a complex protein-DNA-binding domain located within the human immunodeficiency virus type 1 long terminal repeat leader region , 1989, Journal of virology.

[32]  P. Luciw,et al.  Structural arrangements of transcription control domains within the 5'-untranslated leader regions of the HIV-1 and HIV-2 promoters. , 1988, Genes & development.

[33]  R. Gaynor,et al.  Purification of the human immunodeficiency virus type 1 enhancer and TAR binding proteins EBP‐1 and UBP‐1. , 1988, The EMBO journal.

[34]  U. Hansen,et al.  Specific stimulation of simian virus 40 late transcription in vitro by a cellular factor binding the simian virus 40 21-base-pair repeat promoter element. , 1987, Proceedings of the National Academy of Sciences of the United States of America.

[35]  C. Bovolenta,et al.  A selective defect of IFN-gamma- but not of IFN-alpha-induced JAK/STAT pathway in a subset of U937 clones prevents the antiretroviral effect of IFN-gamma against HIV-1. , 1999, Journal of immunology.

[36]  A. Lazzarin,et al.  Hemophilia and nonprogressing human immunodeficiency virus type 1 infection. , 1997, Blood.

[37]  B. Groner,et al.  Mammary gland factor (MGF) is a novel member of the cytokine regulated transcription factor gene family and confers the prolactin response. , 1995, The EMBO journal.

[38]  K. Calame,et al.  An analysis of genes regulated by the multi-functional transcriptional regulator Yin Yang-1. , 1994, Nucleic acids research.

[39]  A. Fauci,et al.  NIH conference. Immunopathogenic mechanisms in human immunodeficiency virus (HIV) infection. , 1991, Annals of internal medicine.